Merck KGaA (OTCMKTS:MKKGY) Sees Significant Decrease in Short Interest

Merck KGaA (OTCMKTS:MKKGY) was the target of a significant drop in short interest during the month of November. As of November 30th, there was short interest totalling 1,600 shares, a drop of 97.2% from the November 15th total of 56,900 shares. Based on an average daily volume of 245,500 shares, the days-to-cover ratio is currently 0.0 days.

Wall Street Analyst Weigh In

Separately, The Goldman Sachs Group began coverage on Merck KGaA in a report on Thursday, September 19th. They issued a “buy” rating for the company.

Merck KGaA Trading Down 0.8 %

Merck KGaA stock traded down $0.24 during trading on Friday, reaching $29.51. The company had a trading volume of 159,143 shares, compared to its average volume of 72,295. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.91 and a current ratio of 1.33. The firm has a market capitalization of $19.07 billion, a price-to-earnings ratio of 18.22, a PEG ratio of 2.37 and a beta of 0.93. Merck KGaA has a 12-month low of $28.96 and a 12-month high of $39.17. The stock’s 50 day moving average price is $32.01 and its two-hundred day moving average price is $34.48.

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.